Crohn's disease, Lancet, vol.389, pp.1741-1755, 2017. ,
, Lancet, vol.389, pp.1756-1770, 2017.
The First European Evidence-based Consensus on Extra-intestinal Manifestations in Inflammatory Bowel Disease, J. Crohns Colitis, vol.10, pp.239-254, 2016. ,
Intravenous Versus Oral Iron for the Treatment of Anemia in Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials, Medicine, vol.95, 2016. ,
European consensus on the diagnosis and management of iron deficiency and anaemia in inflammatory bowel diseases, J. Crohns Colitis, vol.9, pp.211-222, 2015. ,
URL : https://hal.archives-ouvertes.fr/hal-01958873
, Archived: Iron Deficiency Anaemia: Assessment, Prevention and Control, p.24, 2020.
Iron, anaemia, and inflammatory bowel diseases, Gut, vol.53, pp.1190-1197, 2004. ,
URL : https://hal.archives-ouvertes.fr/hal-01958873
Effects of changes in hemoglobin level on quality of life and cognitive function in inflammatory bowel disease patients, Inflamm. Bowel Dis, vol.12, pp.123-130, 2006. ,
Association of extraintestinal manifestations and anaemia with disease outcomes in patients with inflammatory bowel disease, Scand. J. Gastroenterol, vol.51, pp.848-854, 2016. ,
Current practice in the diagnosis and management of IBD-associated anaemia and iron deficiency in Germany: The German AnaemIBD Study, J. Crohns Colitis, vol.8, pp.1308-1314, 2014. ,
Anaemia management in patients with inflammatory bowel disease: Routine practice across nine European countries, Eur. J. Gastroenterol. Hepatol, vol.25, pp.1456-1463, 2013. ,
Iron Replacement in Patients with Inflammatory Bowel Disease: A Systematic Review and Meta-analysis, Inflamm. Bowel Dis, vol.21, 1976. ,
Rational Management of Iron-Deficiency Anaemia in Inflammatory Bowel Disease, Nutrients, vol.10, 2018. ,
Iron replacement therapy in inflammatory bowel disease patients with iron deficiency anemia: A systematic review and meta-analysis, J Crohns Colitis, vol.6, pp.267-275, 2012. ,
Management of Iron-Deficiency Anemia in Inflammatory Bowel Disease: A Systematic Review, Medicine ,
A randomized, open-label, non-inferiority study of intravenous iron isomaltoside 1,000 (Monofer) compared with oral iron for treatment of anemia in IBD (PROCEED), Am. J. Gastroenterol, vol.108, pp.1877-1888, 2013. ,
Ferrous sulfate supplementation causes significant gastrointestinal side-effects in adults: A systematic review and meta-analysis, PLoS ONE, vol.10, 2015. ,
Anaemia from a patient perspective in inflammatory bowel disease: Results from the European Federation of Crohn's and Ulcerative Colitis Association's online survey, Eur. J. Gastroenterol. Hepatol, vol.26, pp.1385-1391, 2014. ,
Iron treatment and inflammatory bowel disease: What happens in real practice?, J. Crohns Colitis, vol.8, pp.876-880, 2014. ,
AEGIS Study Group Ferric maltol is effective in correcting iron deficiency anemia in patients with inflammatory bowel disease: Results from a phase-3 clinical trial program, Inflamm. Bowel Dis, vol.21, pp.579-588, 2015. ,
AEGIS Study Group Ferric maltol therapy for iron deficiency anaemia in patients with inflammatory bowel disease: Long-term extension data from a Phase 3 study, Aliment. Pharmacol. Ther, vol.44, pp.259-270, 2016. ,
Interventions for fatigue in inflammatory bowel disease, Cochrane Database Syst. Rev, 2020. ,
PWE-013 Feraccru®real world effectiveness study in hospital practice (fresh): An interim analysis, Gut, vol.67, 2018. ,
PTU-124 Real world tolerability & efficacy of oral ferric maltol (feraccru) in IBD associated anaemia, Gut, vol.67, pp.252-253, 2018. ,
P331 Productivity loss in patients with inflammatory bowel disease receiving treatment for iron deficiency anaemia: A comparison of ferric maltol and IV iron, J. Crohns Colitis, vol.14, pp.319-320, 2020. ,
P567 Impact of oral ferric maltol and IV iron on health-related quality of life in patients with iron deficiency anaemia and inflammatory bowel disease, and relationship with haemoglobin and serum iron, J. Crohns Colitis, vol.14, pp.478-479, 2020. ,
P685 Healthcare resource use associated with ferric maltol and IV iron treatment for iron deficiency anaemia in patients with inflammatory bowel disease, J. Crohns Colitis, vol.14, 2020. ,
Safety and efficacy of sucrosomial iron in inflammatory bowel disease patients with iron deficiency anemia, Intern. Emerg. Med, vol.14, pp.423-431, 2019. ,
Ferric maltol (ST10): A novel oral iron supplement for the treatment of iron deficiency anemia in inflammatory bowel disease, Expert Opin. Pharmacother, vol.16, pp.2859-2867, 2015. ,
Clinical Characteristics of Coronavirus Disease 2019 in China, N. Engl. J. Med, 2020. ,
, COVID-19 situation reports, p.27, 2020.
Management of IBD during the COVID-19 outbreak: Resetting clinical priorities, Nat. Rev. Gastroenterol. Hepatol, vol.2020, pp.253-255 ,
Gastroenterology department operational reorganisation at the time of covid-19 outbreak: An Italian and Chinese experience, Gut, vol.69, pp.981-983, 2020. ,
Rapid recurrence of IBD-associated anemia and iron deficiency after intravenous iron sucrose and erythropoietin treatment, Am. J. Gastroenterol, vol.104, pp.1460-1467, 2009. ,
, Q&A on Coronaviruses (COVID-19). Available online, p.25, 2020.